Kay Latta Selected Research

Therapeutics

10/2021	Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020.
10/2021	Commentary on "Pediatric Idiopathic Steroid-sensitive Nephrotic Syndrome Diagnosis and Therapy - Short version of the updated German Best Practice Guideline (S2e)".
1/2021	Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
1/2020	A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kay Latta Research Topics

Disease

3	Hereditary Nephritis (Alport Syndrome) 01/2023 - 01/2020
3	Renal Insufficiency (Renal Failure) 01/2021 - 08/2002
2	Proteinuria 01/2022 - 01/2020
2	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021 - 10/2021
2	Growth Disorders 01/2021 - 07/2006
2	Albuminuria 01/2020 - 01/2020
1	Chronic Renal Insufficiency 01/2023
1	Thrombotic Microangiopathies 11/2022
1	COVID-19 11/2022
1	Rare Diseases (Rare Disease) 11/2022
1	Atypical Hemolytic Uremic Syndrome 11/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Sepsis (Septicemia) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Disease Progression 01/2020
1	Kidney Calculi (Kidney Stone) 12/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2006
1	Primary hyperoxaluria type 1 07/2006
1	Mastoiditis 08/2002
1	Relapsing Fever 08/2002
1	Myalgia 08/2002
1	Arthralgia (Joint Pain) 08/2002

Drug/Important Bio-Agent (IBA)

2	AlbuminsIBA 01/2023 - 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	CreatinineIBA 01/2023
1	Exosome Multienzyme Ribonuclease ComplexIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	eculizumab FDA Link 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	PlasticsIBA 01/2021
1	intrinsic factor-cobalamin receptorIBA 01/2020
1	theasinensin AIBA 01/2020
1	LigandsIBA 01/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020
1	VitaminsIBA 01/2020
1	Ramipril (Altace)FDA LinkGeneric 01/2020
1	CalciumIBA 12/2010
1	OxalatesIBA 07/2006
1	Prednisolone (Predate)FDA LinkGeneric 07/2006

Therapy/Procedure

4	Therapeutics 10/2021 - 01/2020
2	Kidney Transplantation 07/2006 - 08/2002
1	Airway Management 01/2021
1	Aftercare (After-Treatment) 08/2002